Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 3
International Journal of Chronic Obstructive Pulmonary Disease
ISSN: 1178-2005
- View all (3550)
- Volume 19, 2024 (64)
- Volume 18, 2023 (251)
- Volume 17, 2022 (253)
- Volume 16, 2021 (311)
- Volume 15, 2020 (325)
- Volume 14, 2019 (296)
- Volume 13, 2018 (397)
- Volume 12, 2017 (364)
- Volume 11, 2016 (343)
- Volume 10, 2015 (274)
- Volume 9, 2014 (134)
- Volume 8, 2013 (76)
- Volume 7, 2012 (84)
- Volume 6, 2011 (74)
- Volume 5, 2010 (49)
- Volume 4, 2009 (43)
- Volume 3, 2008 (83)
- Volume 2, 2007 (74)
- Volume 1, 2006 (54)
Archive: Volume 3, 2008
Gene-environment interactions in chronic obstructive pulmonary disease
Nestor A Molfino, Anthony J Coyle
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:491-497
Published Date: 12 September 2008
Socioeconomic gradients in tiotropium use among adults with COPD
Paul D Blanc, Mark D Eisner, Edward H Yelin, Gillian Earnest, John R Balmes, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:483-490
Published Date: 12 September 2008
Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke
Tapan Bhavsar, Xing Jian Liu, Hardik Patel, Ralph Stephani, Jerome O Cantor
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:477-481
Published Date: 12 September 2008
Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells
Margaretha van der Deen, Sandra Homan, Hetty Timmer-Bosscha, Rik J Scheper, Wim Timens, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:469-475
Published Date: 12 September 2008
Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease
Levent Erkan, Oguz Uzun, Serhat Findik, Didem Katar, Ahmet Sanic, Atilla G Atici
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:463-467
Published Date: 12 September 2008
Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV
Annabel H Nickol, Nicholas Hart, Nicholas S Hopkinson, Carl-Hugo Hamnegård, John Moxham, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:453-462
Published Date: 12 September 2008
Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial
Carel R van Wetering, Floortje E van Nooten, Stijn J M Mol, Martine Hoogendoorn, Maureen P M H Rutten-van Mölken, Annemie M Schols
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:443-451
Published Date: 12 September 2008
Validation of a novel device to objectively measure adherence to long-term oxygen therapy
Sun-Kai V Lin, Daniel K Bogen, Samuel T Kuna
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:435-442
Published Date: 12 September 2008
Modeling the impact of COPD on the brain
Soo Borson, James Scanlan, Seth Friedman, Elizabeth Zuhr, Julie Fields, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:429-434
Published Date: 12 September 2008
Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
Barakat Shahin, Michele Germain, Alzahouri Kazem, Guy Annat
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:423-427
Published Date: 12 September 2008
Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received
Jill Heins-Nesvold, Angeline Carlson, Leslie King-Schultz, Kenneth E Joslyn
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:415-421
Published Date: 12 September 2008
Chronic respiratory effect of narguileh smoking compared with cigarette smoking in women from the East Mediterranean region
Yousser Mohammad, Mouna Kakah, Yasser Mohammad
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:405-414
Published Date: 12 September 2008
Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat® Soft Mist™ Inhaler: findings from two dose-ranging studies in healthy men
Ulrich Feifel, Gudrun Wallenstein, Karl-Ludwig Rominger, Dirk Trommeshauser, Juliane Platz
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:397-403
Published Date: 12 September 2008
The precarious balance between ‘supply’ and ‘demand’ for health care: The increasing global demand for rehabilitation service for individuals living with chronic obstructive pulmonary disease
Michel D Landry, Elham Hamdan, Sabriya Al Mazeedi, Dina Brooks
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:393-396
Published Date: 12 September 2008
Role of arformoterol in the management of COPD
Paul King
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:385-391
Published Date: 12 September 2008
Medication adherence issues in patients treated for COPD
Ruben D Restrepo, Melissa T Alvarez, Leonard D Wittnebel, Helen Sorenson, Richard Wettstein, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:371-384
Published Date: 12 September 2008
Identifying targets for COPD treatment through gene expression analyses
Zhi-Hua Chen, Hong Pyo Kim, Stefan W Ryter, Augustine MK Choi
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:359-370
Published Date: 12 September 2008
Noninvasive ventilation in patients with chronic obstructive airway disease
Gopi C Khilnani, Amit Banga
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:351-357
Published Date: 12 September 2008
Role of macrolide therapy in chronic obstructive pulmonary disease
Fernando J Martinez, Jeffrey L Curtis, Richard Albert
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:331-350
Published Date: 12 September 2008